Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System: The Framingham Heart Study

Background— Leukocyte telomere length (LTL) chronicles the cumulative burden of oxidative stress and inflammation over a life course. Activation of the renin-angiotensin-aldosterone system is associated with increased oxidative stress and inflammation. Therefore, LTL may be related to circulating biomarkers of the renin-angiotensin-aldosterone system. Methods and Results— We evaluated the cross-sectional relations of LTL (dependent variable) to circulating renin and aldosterone concentrations and the renin-to-aldosterone ratio (all logarithmically transformed; independent variables) in 1203 Framingham Study participants (mean age, 59 years; 51% women). We used multivariable linear regression and adjusted for age, blood pressure, hypertension treatment, smoking, diabetes mellitus, body mass index, hormone replacement therapy, serum creatinine, and the urine sodium-to-creatinine ratio. Overall, multivariable-adjusted LTL was inversely related to renin (&bgr; coefficient per unit increase, −0.038; P=0.036), directly related to aldosterone (&bgr;=0.099; P=0.002), and inversely related to the renin-to-aldosterone ratio (&bgr;=−0.049; P=0.003). Relations of LTL to biomarkers were stronger in those with hypertension, although a formal test of interaction was not statistically significant (P=0.20). Individuals with hypertension displayed significant associations of LTL with renin (&bgr;=−0.060; P=0.005), aldosterone (&bgr;=0.134; P=0.002), and renin-to-aldosterone ratio (&bgr;=−0.072; P<0.001). Participants with hypertension who were in the top tertile of the renin-to-aldosterone ratio had LTL that was 182 base pairs shorter relative to those in the lowest tertile. Conclusions— In our community-based sample, LTL was shorter in individuals with a higher renin-to-aldosterone ratio, especially in participants with hypertension. Additional investigations are warranted to confirm our observations.

[1]  G. De Backer,et al.  Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease , 2007, Aging cell.

[2]  E. Blackburn,et al.  Telomere length is paternally inherited and is associated with parental lifespan , 2007, Proceedings of the National Academy of Sciences.

[3]  D. Levy,et al.  Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample , 2007, Hypertension.

[4]  D. Bernhard,et al.  Cigarette smoke – an aging accelerator? , 2007, Experimental Gerontology.

[5]  F. Luft,et al.  Aldosterone, mineralocorticoid receptors, and vascular inflammation , 2007, Current opinion in nephrology and hypertension.

[6]  N. Samani,et al.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2007, The Lancet.

[7]  I. Komuro,et al.  Vascular Cell Senescence: Contribution to Atherosclerosis , 2007, Circulation research.

[8]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[9]  S. Ballinger,et al.  Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. , 2006, Circulation research.

[10]  R. Kronmal,et al.  Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. , 2006, American journal of epidemiology.

[11]  R. Weinberg,et al.  Telomeres: cancer to human aging. , 2006, Annual review of cell and developmental biology.

[12]  T. Spector,et al.  The effects of social status on biological aging as measured by white‐blood‐cell telomere length , 2006, Aging cell.

[13]  D. Levy,et al.  Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study , 2006, Aging cell.

[14]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[15]  T. Spector,et al.  Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. , 2006, American journal of human genetics.

[16]  T. Spector,et al.  Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  A. Aviv,et al.  Aldosterone and telomere length in white blood cells. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  A. Aviv,et al.  Obesity, cigarette smoking, and telomere length in women , 2005, The Lancet.

[19]  A. Aviv,et al.  Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition , 2005, Circulation.

[20]  J. Murabito,et al.  Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. , 2005, American journal of hypertension.

[21]  E. Epel,et al.  Accelerated telomere shortening in response to life stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  F. Boomsma,et al.  Validation of a new automated renin assay. , 2004, Clinical chemistry.

[23]  C. Maser-Gluth,et al.  Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. , 2004, Clinical chemistry.

[24]  D. Postma,et al.  Acute effects of cigarette smoke on inflammation and oxidative stress: a review , 2004, Thorax.

[25]  J. Staessen,et al.  Telomere length and possible link to X chromosome , 2004, The Lancet.

[26]  J. Nicod,et al.  Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism , 2004, Journal of hypertension.

[27]  A. Aviv,et al.  Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects , 2004, Hypertension.

[28]  K. Collins,et al.  Telomere maintenance and disease , 2003, The Lancet.

[29]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[30]  A. Churg.  Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. , 2003, Free radical biology & medicine.

[31]  N. Samani,et al.  White Cell Telomere Length and Risk of Premature Myocardial Infarction , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[32]  R. Cawthon,et al.  Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.

[33]  A. Brasier,et al.  Vascular inflammation and the renin-angiotensin system. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[34]  J. Skurnick,et al.  Telomere Length as an Indicator of Biological Aging: The Gender Effect and Relation With Pulse Pressure and Pulse Wave Velocity , 2001, Hypertension.

[35]  E. Blackburn,et al.  Telomere states and cell fates , 2000, Nature.

[36]  T. von Zglinicki,et al.  Role of Oxidative Stress in Telomere Length Regulation and Replicative Senescence , 2000, Annals of the New York Academy of Sciences.

[37]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[38]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[39]  Jacqueline K. Barton,et al.  Oxidative DNA damage through long-range electron transfer , 1996, Nature.

[40]  D I Boomsma,et al.  Genetic determination of telomere size in humans: a twin study of three age groups. , 1994, American journal of human genetics.

[41]  J. Laragh,et al.  Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. , 1991, The New England journal of medicine.

[42]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[43]  J. Laragh,et al.  Essential hypertension: renin and aldosterone, heart attack and stroke. , 1972, The New England journal of medicine.

[44]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[45]  G. Moneta.  Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive SubjectsBenetos A, Gardner JP, Zureik M, et al (Centre d'Investigations Préventives et Cliniques, Paris; Med School of Nancy, France; INSERM U258, Villejuif, France; et al) Hypertension 43:182–185, 2004§ , 2006 .

[46]  Andrea H. Mason,et al.  Mapping of a major locus that determines telomere length in humans. , 2005, American journal of human genetics.

[47]  F. Luft,et al.  The Mineralocorticoid Receptor and Oxidative Stress , 2005, Heart Failure Reviews.

[48]  R. Grimm,et al.  New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio. , 2002, Ethnicity & disease.

[49]  J. Laragh,et al.  Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. , 1997, American journal of hypertension.

[50]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.

[51]  T. Ito,et al.  A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques. , 1972, The Journal of clinical endocrinology and metabolism.